Epitomics INC:1110226 [16-054396]
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201600633P
- Awardee
-
Epitomics Inc. UEI GHX3CZALWZT9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,652
Award facts
- Contract value 100% obligated
- $6,652.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,100 | |
| Original award | $8,752 |
About this award
The National Cancer Institute awarded a purchase order to Epitomics Inc. valued at $6,652.06 on August 29, 2016. Performance occurs at the awardee's Bethesda, Maryland facility. The order is priced on a firm fixed price basis with an ultimate completion date of September 29, 2016. No set-aside category was applied.
Quick answers
Who was awarded contract HHSN261201600633P?
HHSN261201600633P was awarded to Epitomics Inc. by National Cancer Institute (National Institutes of Health) on August 29, 2016.
How much is contract HHSN261201600633P worth?
The government has obligated $6,652 on HHSN261201600633P.
Was contract HHSN261201600633P competed?
The extent of competition for HHSN261201600633P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award